4 Reddit Questions About GLP-1s, Answered by Obesity Experts

People frequently turn to Reddit to ask questions and share advice about taking glucagon-like peptide-1 (GLP-1) medication to manage obesity. But even if what you read there sounds convincing, it’s not always medically accurate or helpful.

That’s why we combed Reddit to find out what people are currently talking about in obesity and GLP-1 communities and asked the following medical experts to respond to readers’ most pressing questions:

Many Reddit users report GLP-1 side effects such as constipation, diarrhea, fatigue, low appetite, and nausea. Discussions frequently focus on practical ways to manage symptoms, such as eating smaller meals, increasing fiber intake, and staying hydrated. At the same time, many posters question when things warrant a discussion with their doctor.

Marsha Novick: Mild nausea, constipation, diarrhea, fatigue, and low appetite are fairly common with GLP-1 medications like semaglutide (Wegovy) and tirzepatide (Zepbound), especially in the first few days after an injection or after a dose increase.

Richele Corrado: In many cases, these symptoms improve as your body adjusts to the medication. However, side effects should not be severe or significantly interfere with daily functioning, nutrition, or hydration. Speak with your healthcare provider if side effects become difficult to manage, do not improve, or begin affecting your ability to eat and drink adequately. Dose adjustments, slower titration [dose increase] schedules, hydration strategies, nutrition counseling, and other symptom-management approaches can often help improve tolerability.

Sherrie Singh-Bryan: Eating balanced, small portions, staying hydrated, and getting adequate exercise are all nonmedical interventions that help improve side effects. Discussing your symptoms with your [healthcare] provider and adhering to treatment plans, such as taking stool softeners and antacids, are also important.

Kia Mitchell: You also need to prepare for red flags. If you experience pain in your upper belly, especially if it’s moving toward your back; yellowing of your skin or eyes; or you can’t keep down fluids for 24 hours, get to your closest emergency room. [These could be signs of] pancreatitis, gallbladder issues, or dehydration. A neck mass with difficulty swallowing is another red flag [to get checked].

Many Reddit users share weight loss milestones, progress photos, and personal stories about their success with GLP-1 medications. While some posts highlight dramatic changes, others emphasize slow, steady progress. Together, these discussions often leave people wondering what realistic weight loss results look like and whether their own experience is typical.

KM: Realistic weight loss is different from person to person. Losing around one to two pounds each week is ideal, but sometimes you’ll see more and sometimes, none at all. The main goal is to make healthy, sustainable changes that will help maintain weight loss.

SS: Balancing personal expectations with healthy goals can prove challenging for many people. Discussing both scale and nonscale goals while developing a treatment plan helps with goal setting. For example, a scale goal would be to lose four to eight pounds each month, or 7 to 10 percent of your overall weight in six months. A nonscale goal would be to be able to climb stairs without being out of breath.

MN: Just like any other medication, GLP-1s may not work the same way for everyone. Results depend on individual factors like underlying health conditions, other medications you might be taking, and whether you’re making lifestyle changes with improved nutrition, physical activity, sleep, and stress management. So, for instance, in people without diabetes who are taking tirzepatide, along with making lifestyle changes, studies show about a 22 percent loss of body weight over a year, while those taking semaglutide typically lose around 14 to 15 percent.

RC: These medications are not just about the number on the scale. Even modest weight loss of 5 to 10 percent can lead to meaningful improvements in blood sugar, blood pressure, metabolic liver disease, sleep apnea, joint pain, cardiovascular risk, and overall health. Ultimately, the goal is not rapid or extreme weight loss but, rather, safe, sustainable, and medically meaningful improvements in health and quality of life.

Reddit users often post about experiencing a weight loss plateau while taking a GLP-1 medication, even after an initial period of steady progress. Discussions tend to normalize stalls and often lead to sharing advice on how to adjust your routine to get the scale moving again.

RC: Yes, weight loss plateaus are completely normal and expected on GLP-1 medications, and weight loss is rarely linear. Plateaus can happen for many reasons, so it’s important to talk with your healthcare provider to help identify possible contributors.

SS: Moving past a plateau begins with reassessing your plan: Is anything missing? Did you stop exercising ? Are you off schedule? Addressing factors affecting your weight loss journey will typically resume your weight loss.

MN: Continuing to focus on lifestyle habits can make a big difference, including working with a dietitian to make sure nutrition is well balanced, adding strength or weight training, improving sleep, managing stress, and reviewing whether any other medications could be contributing [to plateaus]. In addition, other non–GLP-1 medications may be added to jump-start weight loss progress.

KM: Even though plateaus are totally normal, they can be discouraging. That’s where we celebrate your small victories like being consistent and working out five days this week, getting your steps in, lifting heavier, or meeting your water goals.

Reddit users frequently discuss the financial challenges of GLP-1s and worry what might happen with their progress if costs get in the way of treatment. Many ask around to compare what others are paying and explore ways to reduce out-of-pocket expenses while maintaining access to treatment. Some also raise questions and concerns about compounded options, highlighting the uncertainty people feel when affordability becomes a treatment barrier.

SS: Medication affordability and availability can be challenging. Be consistent with other aspects of your journey; keep exercising and managing your diet. Having a discussion with your healthcare provider is also very important to determine the best options available to you.

RC: Talk with your healthcare provider before stopping the medication, as there may be more affordable options available. Manufacturer self-pay programs, direct-to-consumer pharmacy options, savings cards, or discount programs, such as GoodRx, can help reduce the cost of medications like semaglutide or tirzepatide.

If GLP-1 medications are still not affordable, discuss alternative obesity medications with your provider. Medications such as metformin [Glucophage], phentermine [Adipex-P], topiramate [Topamax], bupropion [Wellbutrin], and naltrexone [Revia] (sometimes used alone or in combination, [such as Contrave]) can be effective and are often available as inexpensive generics, sometimes for as little as $10 to $20 per month.

Lastly, for those who are eligible, metabolic/bariatric surgery should remain part of the conversation, as it is one of the most effective and durable obesity treatments we have.

MN: I recommend avoiding the compounded versions of GLP-1 medications. Even if they are less expensive, they’re not [approved by the U.S. Food and Drug Administration], and safety and quality can vary. People usually get the safest and most effective care by working closely with their primary care provider or a board-certified obesity medicine physician [if they can no longer afford the medication].

KM: Many people are caught between a rock and a hard place financially, and there are some hard choices we have to make about these medications. But we have options. For example, if you’re close to your goals and considering maintenance, then we can discuss more financially practical options, but it is always about weighing the risks versus the benefits.